Jefferies Financial Group
VRTX icon

Jefferies Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Jefferies Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.89M Sell
15,089
-8,065
-35% -$4.13M 0.06% 228
2026
Q2 		$11.5M Sell
23,154
-656
-3% -$291K 0.08% 226
2026
Q1 		$10.6M Sell
23,810
-7,562
-24% -$3.53M 0.07% 199
2025
Q4 		$14.2M Buy
31,372
+15,372
+96% +$6.63M 0.07% 258
2025
Q3 		$6.27M Sell
16,000
-18,615
-54% -$7.78M 0.03% 310
2025
Q2 		$15.4M Buy
34,615
+15,131
+78% +$6.97M 0.13% 120
2025
Q1 		$9.45M Buy
19,484
+5,500
+39% +$2.56M 0.08% 165
2024
Q4 		$5.63M Sell
13,984
-18,659
-57% -$8.65M 0.03% 337
2024
Q3 		$15.2M Sell
32,643
-27,632
-46% -$13.3M 0.11% 119
2024
Q2 		$28.3M Buy
60,275
+3,453
+6% +$1.5M 0.3% 53
2024
Q1 		$23.8M Buy
56,822
+38,814
+216% +$16.4M 0.22% 70
2023
Q4 		$7.33M Buy
18,008
+17,707
+5,883% +$6.54M 0.05% 301
2023
Q3 		$105K Sell
301
-10,632
-97% -$3.72M ﹤0.01% 1449
2023
Q2 		$3.85M Sell
10,933
-191
-2% -$64.4K 0.03% 421
2023
Q1 		$3.5M Buy
11,124
+3,636
+49% +$1.09M 0.03% 469
2022
Q4 		$2.16M Buy
+7,488
New +$2.28M 0.02% 629
2016
Q2 		– Sell
-3,300
Closed -$262K – 71
2016
Q1 		$262K Buy
+3,300
New +$298K 0.04% 30

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Jefferies Financial Group's VRTX Position: Q3 2026 in Review

Jefferies Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 35% in Q3 2026, selling an estimated $4.13M and leaving 15,089 shares worth $7.89M. The position accounts for 0.06% of the portfolio, ranked #228.

Jefferies Financial Group first reported a position in VRTX in Q1 2016 and has held it in 17 quarters since. The position peaked at $28.3M in Q2 2024. 1,161 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Jefferies Financial Group held 15,089 shares of Vertex Pharmaceuticals worth $7.89M as of Q3 2026.
  • Jefferies Financial Group sold 8,065 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.13M.
  • Vertex Pharmaceuticals made up 0.06% of Jefferies Financial Group's portfolio in Q3 2026, its #228 holding.
  • Jefferies Financial Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 17 quarters since.
  • Jefferies Financial Group's Vertex Pharmaceuticals position peaked at $28.3M in Q2 2024.
  • 1,161 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.